|
|||||
|
|
Control of relapse due to minimal residual disease (MRD) by cell-mediated cytokine-activated immunotherapy in conjunction with bone marrow transplantation |
|
| Affiliation: | 1. Department of Physics, Technische Universität München, Garching, Germany;1. Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden;2. Department of Urology, Skåne University Hospital, Lund University, Malmö, Sweden |
| Abstract: | |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ | |